Alector, Inc

(NASDAQ:ALEC)

Latest On Alector, Inc (ALEC):

Date/Time Type Description Signal Details
2023-05-04 22:00 ESTNewsAlector GAAP EPS of -$0.55, revenue of $16.5MN/A
2023-03-01 07:09 ESTNewsAlector GAAP EPS of -$0.63 misses by $0.09, revenue of $14.44M misses by $11.44MN/A
2023-02-03 18:01 ESTNewsAlector: Trading At Cash Despite Late Stage CNS PipelineN/A
2022-11-10 12:40 ESTNewsAlector hits 52-week low after Q3 results as analysts focus on pipelineN/A
2022-11-09 19:54 ESTNewsAlector hits 52-week after Q3 results as analysts focus on pipelineN/A
2022-11-09 01:55 ESTNewsAlector GAAP EPS of -$0.56 misses by $0.09, revenue of $14.85M misses by $16.54MN/A
2022-11-04 15:26 ESTNewsAlector: Lots Of Long Term Potential, Lots Of CashN/A
2022-10-04 12:50 ESTNewsAlector: Advancement Of Third Alzheimer's Drug Brings About Huge PotentialN/A
2022-09-09 17:52 ESTNewsAlector stock falls 12% as Morgan Stanley cuts rating on long path for AL001N/A
2022-08-04 23:03 ESTNewsAlector GAAP EPS of $0.12 beats by $0.60, revenue of $79.85M beats by $49.81MN/A
2022-07-08 14:52 ESTNewsAbbVie ends partnership with Alector for Alzheimer’s candidateN/A
2022-06-15 04:50 ESTNewsAlector: Potential In Neurology And Cancer TreatmentsN/A
2022-05-05 20:55 ESTNewsAlector GAAP EPS of -$0.54 misses by $1.22, revenue of $24.5MN/A
2022-04-16 14:49 ESTNewsAlector: Expect Phase 3 Data Next YearN/A
2022-03-29 21:35 ESTNewsAlector names new medical chiefN/A
2022-03-24 03:11 ESTNewsAlector (ALEC) Presents Twelve Month ResultsN/A
2022-03-09 02:51 ESTNewsAlector downgraded at Stifel on prospects for late-stage dementia candidateN/A
2022-02-25 04:06 ESTNewsAlector GAAP EPS of -$0.68 misses by $0.75, revenue of $14M misses by $69.82MN/A
2022-02-07 17:25 ESTNewsAlector appoints new finance chiefN/A
2022-01-26 17:22 ESTNewsAlector, Inc: A Newer Biotech Company With Big PotentialN/A
2021-11-05 00:41 ESTNewsAlector EPS misses by $1.49, misses on revenueN/A
2021-10-30 07:25 ESTNewsAlector: The GSK Deal Is A Major Value AddN/A
2021-09-21 11:39 ESTNewsAlector EPS misses by $0.01, misses on revenueN/A
2021-09-09 19:55 ESTNewsDosing underway in Alector's Phase 2 AL001 study in amyotrophic lateral sclerosisN/A
2021-09-08 23:42 ESTNewsAlector slides as two top executives plan to leaveN/A
2021-07-29 13:32 ESTNewsAlector phase 2 data on AL001 shows benefit in frontotemporal dementia (updated)N/A
2021-07-25 00:07 ESTNewsAAIC 2021: What to look for at Alzheimer's biggest annual conferenceN/A
2021-07-20 18:34 ESTNewsCentogene, Alector initiate EFRONT study in frontotemporal dementiaN/A
2021-07-20 18:31 ESTNewsMerus upgraded on ASCO update, Cantor favors Harpoon after selloff; and more in today’s analyst actionN/A
2021-07-20 18:19 ESTNewsAlector surges on deal with GSK for experimental drugs targeting neurological diseasesN/A
2021-07-20 18:12 ESTNewsAlector leads weekly healthcare gainers; gene-editing stocks fall after Intellia-driven rallyN/A
2021-05-06 06:55 ESTNewsAlector EPS in-line, misses on revenueN/A
2021-03-19 11:29 ESTNewsAlector up 18% after patent application published for Alzheimer's programN/A
2021-03-01 11:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $32.13 to $31.88.Neutral
2021-03-01 11:04 ESTEarnings EstimateAn EPS average of -$2.84 is estimated for the 2022 year.Sell
2021-03-01 11:04 ESTEarnings EstimateAn EPS average of -$0.72 is estimated for the quarter ending on June 30, 2021.Sell
2021-02-26 15:03 ESTFinancialsCompany financials have been released.Neutral
2021-02-25 18:56 ESTNewsAlector EPS misses by $0.02, misses on revenueN/A
2021-01-25 12:50 ESTNewsDoing underway in Alector, AbbVie's study of AL002 in Alzheimer’s diseaseN/A
2021-01-21 05:34 ESTNewsAlector's business chief steps downN/A
2021-01-18 07:04 ESTAnalyst RatingThe Analyst Target Price has increased from $31.71 to $32.13.Buy
2021-01-15 07:04 ESTAnalyst RatingThe Analyst Target Price has decreased from $31.88 to $31.71.Neutral
2021-01-07 22:34 ESTNewsAlector gives update on its frontotemporal dementia and Alzheimer’s disease trialsN/A
2020-12-28 20:51 ESTNewsAlector: Activating Microglia To Treat NeurodegenerationN/A
2020-12-24 15:06 ESTAnalyst RatingThe Analyst Target Price has decreased from $33.63 to $31.88.Neutral
2020-12-13 03:08 ESTFinancialsCompany financials have been released.Neutral
2020-12-11 15:06 ESTFinancialsCompany financials have been released.Neutral
2020-12-07 21:17 ESTNewsAlector: AL001's Phase 3 Initiation/Phase 2 Readout In 2021, $462M In Cash, And AbbVie's Promising Support, +38% UpsideN/A
2020-11-25 11:10 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 11:07 ESTAnalyst RatingThe Analyst Target Price has decreased from $34.75 to $33.63.Neutral

About Alector, Inc (ALEC):

Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis diseases; and AL101 that is in Phase I clinical trial for the treatment of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases. The company also offers AL002, a product candidate that is in Phase II clinical trial for the treatment of Alzheimer's disease; and AL003, which is in Phase Ib clinical trial for the treatment of Alzheimer's disease. In addition, its products in development stage include AL044 that targets MS4A4A, a risk gene for Alzheimer's disease; and 8 candidates in immuno-neurology/immuno-oncology field comprise ADP012, ADP016, ADP017, ADP023, ADP026, ADP122, ADP009, and ADP022. Alector, Inc. has a collaboration agreement with Adimab, LLC for the research and development of antibodies. The company was founded in 2013 and is headquartered in South San Francisco, California.

ALEC Quotes by TradingView

See Advanced Chart

General

  • Name Alector, Inc
  • Symbol ALEC
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 171
  • Fiscal Year EndDecember
  • IPO Date2019-02-07
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.alector.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 68.96
  • Price/Book (Most Recent Quarter) 5.57
  • Enterprise Value Revenue 53.42
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.90
  • Next Year EPS Estimate -$2.61
  • Next Quarter EPS Estimate -$0.69
  • Operating Margin -924%
  • Return on Assets -27%
  • Return on Equity -82%
  • Revenue 21.1 million
  • Earnings Per Share -$2.26
  • Revenue Per Share $0.27
  • Gross Profit -135771000
  • Quarterly Earnings Growth -19.1%
View More

Highlights

  • Market Capitalization 1.43 billion
  • EBITDA -80913000
  • PE Ratio -3.72
  • Analyst Target Price $31.88
  • Book Value Per Share $3.37
View More

Share Statistics

  • Shares Outstanding 79.58 million
  • Shares Float 56.59 million
  • % Held by Insiders 1281%
  • % Held by Institutions 78.94%
  • Shares Short 5.41 million
  • Shares Short Prior Month 5.05 million
  • Short Ratio 9.62
  • Short % of Float 12%
  • Short % of Shares Outstanding 7%
View More

Technicals

  • Beta 1.04
  • 52 Week High $34.89
  • 52 Week Low $9.12
  • 50 Day Moving Average 18.61
  • 200 Day Moving Average 14.44
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Alector, Inc (ALEC) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Alector, Inc (ALEC) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-25$4.85 million-$0.66-$0.65-1.93%
2020-09-302020-11-10$N/A-$0.67-$0.55-22.53%
2020-06-302020-08-11$N/A-$0.58-$0.50-14.99%
2020-03-312020-05-13$7.17 million-$0.53-$0.43-22.69%
2019-12-312020-03-24$6 million-$0.45-$0.44-1.69%
2019-09-302019-11-12$2.7 million-$0.47-$0.40-17.5%
2019-06-302019-08-12$6.92 million-$0.36-$0.32-12.5%
2019-03-312019-05-13$5.61 million-$0.27-$0.3214.29%
2018-12-312019-03-26$9.15 million-$0.27-$0.27-0.37%

Alector, Inc (ALEC) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Alector, Inc (ALEC) Chart:

Alector, Inc (ALEC) News:

Below you will find a list of latest news for Alector, Inc (ALEC) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Alector, Inc (ALEC) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50CALL0 0290.56TRUE00
2024-05-1751.35CALL0 3289.24TRUE00
2024-05-177.50.2CALL0 20FALSE00
2024-05-17100CALL0 00FALSE00
2024-05-1712.50CALL0 00FALSE00
2024-05-172.50PUT0 00FALSE00
2024-05-1750.2PUT0 160.71FALSE00
2024-05-177.52.5PUT1 0108.81TRUE2.50
2024-05-17100PUT0 0253.88TRUE00
2024-05-1712.50PUT0 0618.7TRUE00
2024-07-192.52.75CALL3 17128.42TRUE-0.25-0.08
2024-07-1951.3CALL0 496.21TRUE00
2024-07-197.50.3CALL0 25473.09FALSE00
2024-07-19100.35CALL0 550FALSE00
2024-07-1912.50.23CALL0 300FALSE00
2024-07-19150.19CALL0 390FALSE00
2024-07-192.50.23PUT0 50FALSE00
2024-07-1950.22PUT0 1163.81FALSE00
2024-07-197.51.72PUT0 35172.38TRUE00
2024-07-19103.4PUT0 0191.62TRUE00
2024-07-1912.50PUT0 0219.06TRUE00
2024-07-19150PUT0 0245.5TRUE00
2024-10-182.50CALL0 0113.53TRUE00
2024-10-1852.35CALL0 775.38TRUE00
2024-10-187.50.9CALL0 696.02FALSE00
2024-10-18100.05CALL0 13083.48FALSE00
2024-10-1812.50.45CALL0 200FALSE00
2024-10-182.50.23PUT0 10FALSE00
2024-10-1850.88PUT0 170.98FALSE00
2024-10-187.51.85PUT0 385.01TRUE00
2024-10-18100PUT0 093.86TRUE00
2024-10-1812.50PUT0 0165.51TRUE00
2025-01-172.50CALL0 0134.12TRUE00
2025-01-1752.85CALL0 2120.33TRUE00
2025-01-177.52CALL0 796124.8FALSE00
2025-01-17101.35CALL0 550FALSE00
2025-01-1712.50.6CALL0 150115.18FALSE00
2025-01-17150CALL0 00FALSE00
2025-01-172.50PUT0 0114.49FALSE00
2025-01-1751.75PUT2 35113.2FALSE0.10.06
2025-01-177.50PUT0 0109.15TRUE00
2025-01-17103.8PUT0 5104.47TRUE00
2025-01-1712.50PUT0 0108.84TRUE00
2025-01-17150PUT0 0142.11TRUE00

Latest ALEC Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$7.83
Jun 13, 2022 7:59 PM EST56$7.83
Jun 13, 2022 7:59 PM EST52$7.83
Jun 13, 2022 7:59 PM EST80$7.83
Jun 13, 2022 7:59 PM EST11$7.83

Alector, Inc (ALEC) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000089924320017687/0000899243-20-017687-index.htm
2018-11-07UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1653087/000000000018034674/0000000000-18-034674-index.htm
2018-12-04UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1653087/000000000018037148/0000000000-18-037148-index.htm
2018-12-20UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1653087/000000000018038840/0000000000-18-038840-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000089924320017680/0000899243-20-017680-index.htm
2020-06-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000089924320017687/0000899243-20-017687-index.htm
2019-02-20SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787119000130/0000947871-19-000130-index.htm
2019-08-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787119000575/0000947871-19-000575-index.htm
2019-08-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787119000576/0000947871-19-000576-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787119000977/0000947871-19-000977-index.htm
2019-12-19SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787119000979/0000947871-19-000979-index.htm
2019-12-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2020-01-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000022/0000947871-20-000022-index.htm
2020-01-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000023/0000947871-20-000023-index.htm
2020-02-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000087/0000947871-20-000087-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000183/0000947871-20-000183-index.htm
2020-03-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000184/0000947871-20-000184-index.htm
2020-03-24144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000254/0000947871-20-000254-index.htm
2020-03-24144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000255/0000947871-20-000255-index.htm
2020-03-254Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-30144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000302/0000947871-20-000302-index.htm
2020-03-30144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000303/0000947871-20-000303-index.htm
2020-04-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000317/0000947871-20-000317-index.htm
2020-04-09144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000369/0000947871-20-000369-index.htm
2020-04-09144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000370/0000947871-20-000370-index.htm
2020-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-04-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000387/0000947871-20-000387-index.htm
2020-04-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm
2020-06-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000541/0000947871-20-000541-index.htm
2020-07-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000614/0000947871-20-000614-index.htm
2020-07-16SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1653087/000094787120000626/0000947871-20-000626-index.htm
2018-10-12DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1653087/000095012318009894/0000950123-18-009894-index.htm
2018-10-12DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1653087/000095012318009895/0000950123-18-009895-index.htm
2018-11-16DRS/ADraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1653087/000095012318012133/0000950123-18-012133-index.htm
2018-11-16DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1653087/000095012318012135/0000950123-18-012135-index.htm
2018-12-17DRSLTRCorrespondence Related to Draft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1653087/000095012318012426/0000950123-18-012426-index.htm
2019-12-02DRSDraft Registration Statementhttps://www.sec.gov/Archives/edgar/data/1653087/000095012319011700/0000950123-19-011700-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1653087/000110465919008620/0001104659-19-008620-index.htm
2019-01-07S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1653087/000119312519003772/0001193125-19-003772-index.htm
2019-01-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1653087/000119312519003779/0001193125-19-003779-index.htm
2019-01-07CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1653087/000119312519003784/0001193125-19-003784-index.htm
2019-01-29S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1653087/000119312519019648/0001193125-19-019648-index.htm
2019-01-318-A12BRegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/1653087/000119312519024072/0001193125-19-024072-index.htm
2019-02-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1653087/000119312519026990/0001193125-19-026990-index.htm
2019-02-04CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1653087/000119312519026991/0001193125-19-026991-index.htm
2019-02-06S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1653087/000119312519029514/0001193125-19-029514-index.htm
2019-02-06FWPFiling under Securities Act Rules 163/433 of free writing prospectuseshttps://www.sec.gov/Archives/edgar/data/1653087/000119312519029585/0001193125-19-029585-index.htm
2019-02-07424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1653087/000119312519030566/0001193125-19-030566-index.htm
2019-02-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1653087/000119312519030597/0001193125-19-030597-index.htm
2019-02-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000119312519033930/0001193125-19-033930-index.htm
2019-03-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1653087/000119312519088558/0001193125-19-088558-index.htm
2019-03-27DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1653087/000119312519088567/0001193125-19-088567-index.htm
2019-06-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000119312519172525/0001193125-19-172525-index.htm
2020-01-27S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1653087/000119312520015336/0001193125-20-015336-index.htm
2020-01-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1653087/000119312520015374/0001193125-20-015374-index.htm
2020-01-27CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1653087/000119312520015381/0001193125-20-015381-index.htm
2020-01-29S-1/AGeneral form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1653087/000119312520017882/0001193125-20-017882-index.htm
2020-01-29S-1MEFRegistration adding securities to prior Form S-1 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1653087/000119312520018822/0001193125-20-018822-index.htm
2020-01-30424B4Prospectus [Rule 424(b)(4)]https://www.sec.gov/Archives/edgar/data/1653087/000119312520019151/0001193125-20-019151-index.htm
2020-02-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000119312520024249/0001193125-20-024249-index.htm
2020-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1653087/000119312520033331/0001193125-20-033331-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000119312520067324/0001193125-20-067324-index.htm
2020-05-13S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1653087/000119312520141645/0001193125-20-141645-index.htm
2020-05-13424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1653087/000119312520141685/0001193125-20-141685-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000119312520141724/0001193125-20-141724-index.htm
2020-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000119312520143955/0001193125-20-143955-index.htm
2019-02-11SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1653087/000119380519000158/0001193805-19-000158-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007883/0001209191-19-007883-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007884/0001209191-19-007884-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007885/0001209191-19-007885-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007886/0001209191-19-007886-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007887/0001209191-19-007887-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007889/0001209191-19-007889-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007890/0001209191-19-007890-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007892/0001209191-19-007892-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007894/0001209191-19-007894-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007896/0001209191-19-007896-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007898/0001209191-19-007898-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007925/0001209191-19-007925-index.htm
2019-02-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119007926/0001209191-19-007926-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009111/0001209191-19-009111-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009113/0001209191-19-009113-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009114/0001209191-19-009114-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009118/0001209191-19-009118-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009119/0001209191-19-009119-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009780/0001209191-19-009780-index.htm
2019-02-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119009784/0001209191-19-009784-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119029727/0001209191-19-029727-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119029732/0001209191-19-029732-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119029734/0001209191-19-029734-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119029736/0001209191-19-029736-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119029740/0001209191-19-029740-index.htm
2019-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119029743/0001209191-19-029743-index.htm
2019-08-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119045559/0001209191-19-045559-index.htm
2019-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119045564/0001209191-19-045564-index.htm
2019-08-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119046647/0001209191-19-046647-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119046979/0001209191-19-046979-index.htm
2019-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119046985/0001209191-19-046985-index.htm
2019-09-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119050106/0001209191-19-050106-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119050589/0001209191-19-050589-index.htm
2019-09-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119050590/0001209191-19-050590-index.htm
2019-10-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119053486/0001209191-19-053486-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119055820/0001209191-19-055820-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119055823/0001209191-19-055823-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119055826/0001209191-19-055826-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119055827/0001209191-19-055827-index.htm
2019-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119055829/0001209191-19-055829-index.htm
2019-11-194/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119057197/0001209191-19-057197-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119057201/0001209191-19-057201-index.htm
2019-11-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119057203/0001209191-19-057203-index.htm
2019-12-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119059299/0001209191-19-059299-index.htm
2019-12-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2019-12-123Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119060223/0001209191-19-060223-index.htm
2019-12-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119060225/0001209191-19-060225-index.htm
2019-12-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119060784/0001209191-19-060784-index.htm
2019-12-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919119060931/0001209191-19-060931-index.htm
2020-01-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120004048/0001209191-20-004048-index.htm
2020-01-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120004706/0001209191-20-004706-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120005031/0001209191-20-005031-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120005034/0001209191-20-005034-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm
2020-01-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120005056/0001209191-20-005056-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120006109/0001209191-20-006109-index.htm
2020-02-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120006112/0001209191-20-006112-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120007209/0001209191-20-007209-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120007210/0001209191-20-007210-index.htm
2020-02-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120007250/0001209191-20-007250-index.htm
2020-02-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120007732/0001209191-20-007732-index.htm
2020-02-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2020-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120008414/0001209191-20-008414-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120010234/0001209191-20-010234-index.htm
2020-02-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120010241/0001209191-20-010241-index.htm
2020-03-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm
2020-03-243Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120021014/0001209191-20-021014-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120021016/0001209191-20-021016-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120024871/0001209191-20-024871-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120028986/0001209191-20-028986-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120028991/0001209191-20-028991-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120028993/0001209191-20-028993-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120028995/0001209191-20-028995-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120028997/0001209191-20-028997-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120029004/0001209191-20-029004-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120030601/0001209191-20-030601-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120030604/0001209191-20-030604-index.htm
2020-06-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120034702/0001209191-20-034702-index.htm
2020-06-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120037254/0001209191-20-037254-index.htm
2020-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120042869/0001209191-20-042869-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120053597/0001209191-20-053597-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120053599/0001209191-20-053599-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120053605/0001209191-20-053605-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120053606/0001209191-20-053606-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120053612/0001209191-20-053612-index.htm
2020-10-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000120919120053614/0001209191-20-053614-index.htm
2019-02-04CERTCertificationhttps://www.sec.gov/Archives/edgar/data/1653087/000135445719000055/0001354457-19-000055-index.htm
2019-03-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019009355/0001564590-19-009355-index.htm
2019-03-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1653087/000156459019009358/0001564590-19-009358-index.htm
2019-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019018836/0001564590-19-018836-index.htm
2019-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1653087/000156459019018837/0001564590-19-018837-index.htm
2019-05-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019019627/0001564590-19-019627-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019031472/0001564590-19-031472-index.htm
2019-08-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019031482/0001564590-19-031482-index.htm
2019-08-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1653087/000156459019031488/0001564590-19-031488-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019042915/0001564590-19-042915-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1653087/000156459019042920/0001564590-19-042920-index.htm
2019-12-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019045755/0001564590-19-045755-index.htm
2019-12-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459019045969/0001564590-19-045969-index.htm
2020-03-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459020012509/0001564590-20-012509-index.htm
2020-03-2410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1653087/000156459020012520/0001564590-20-012520-index.htm
2020-03-24S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1653087/000156459020012557/0001564590-20-012557-index.htm
2020-03-30DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1653087/000156459020014173/0001564590-20-014173-index.htm
2020-03-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1653087/000156459020014205/0001564590-20-014205-index.htm
2020-05-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459020024870/0001564590-20-024870-index.htm
2020-05-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1653087/000156459020025043/0001564590-20-025043-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459020039316/0001564590-20-039316-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1653087/000156459020039319/0001564590-20-039319-index.htm
2020-10-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1653087/000156459020045922/0001564590-20-045922-index.htm
2020-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1653087/000162363220000229/0001623632-20-000229-index.htm
2015-09-16DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1653087/000165308715000001/0001653087-15-000001-index.htm
2019-02-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1653087/999999999519000107/9999999995-19-000107-index.htm
2020-01-29EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1653087/999999999520000190/9999999995-20-000190-index.htm
2019-02-06CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1653087/999999999719000119/9999999997-19-000119-index.htm

Alector, Inc (ALEC) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Alector, Inc (ALEC). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1281%
Institutional Ownership: 7894%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-03-02ORBIMED ADVISORS LLC10% Share HolderSell38,808.0026.001,009,008.000.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000183/0000947871-20-000183-index.htm
2019-02-11CARL L GORDONDirectorBuy157,939.0019.003,000,841.0010,434,976.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119009111/0001209191-19-009111-index.htm
2019-02-11ORBIMED ADVISORS LLCDirectorBuy157,939.0019.003,000,841.0010,434,976.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119009118/0001209191-19-009118-index.htm
2020-02-07Calvin YuVice President, FinanceSell24,033.0035.02841,635.66110,686.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2020-06-03Calvin YuVice President, FinanceSell300.0032.029,606.00110,686.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120034702/0001209191-20-034702-index.htm
2020-06-03Calvin YuVice President, FinanceSell1,043.0031.0432,374.72110,986.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120034702/0001209191-20-034702-index.htm
2020-02-06Calvin YuVice President, FinanceSell2,621.0035.0091,735.00124,494.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2020-02-04Calvin YuVice President, FinanceSell63,541.0030.041,908,771.64125,294.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007209/0001209191-20-007209-index.htm
2020-02-06Calvin YuVice President, FinanceBuy1,096.008.168,943.36126,390.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2020-02-06Calvin YuVice President, FinanceBuy725.0010.147,351.50127,115.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2020-02-07Calvin YuVice President, FinanceBuy2,825.008.1623,052.00127,319.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2020-06-23Polaris Venture Management Co. VI, L.L.C.10% Share HolderSell4,377.0031.54138,062.8412,853,817.00https://www.sec.gov/Archives/edgar/data/1653087/000089924320017680/0000899243-20-017680-index.htm
2020-06-23TERRANCE MCGUIREDirectorSell4,377.0031.54138,062.8412,853,817.00https://www.sec.gov/Archives/edgar/data/1653087/000089924320017687/0000899243-20-017687-index.htm
2020-02-07Calvin YuVice President, FinanceBuy7,400.0010.1475,036.00134,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007942/0001209191-20-007942-index.htm
2019-12-03Calvin YuVice President, FinanceSell1,315.0018.3124,077.65175,294.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059299/0001209191-19-059299-index.htm
2020-02-04Calvin YuVice President, FinanceBuy13,541.008.16110,494.56188,835.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007209/0001209191-20-007209-index.htm
2020-04-16ORBIMED ADVISORS LLC10% Share HolderSell15,086.0023.53354,973.581,906,718.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm
2020-04-14ORBIMED ADVISORS LLC10% Share HolderSell5,636.0023.52132,558.721,921,804.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm
2020-04-09ORBIMED ADVISORS LLC10% Share HolderSell69,893.0023.791,662,754.471,927,440.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-04-08ORBIMED ADVISORS LLC10% Share HolderSell20,041.0023.65473,969.651,997,333.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-04-07ORBIMED ADVISORS LLC10% Share HolderSell2,224.0023.1051,374.402,017,374.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-03-31ORBIMED ADVISORS LLC10% Share HolderSell60,645.0024.501,485,802.502,019,598.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000317/0000947871-20-000317-index.htm
2019-02-11CARL L GORDONDirectorBuy203,200.0019.003,860,800.00203,200.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119009111/0001209191-19-009111-index.htm
2019-02-11ORBIMED ADVISORS LLCDirectorBuy203,200.0019.003,860,800.00203,200.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119009118/0001209191-19-009118-index.htm
2020-03-25ORBIMED ADVISORS LLC10% Share HolderSell13,684.0024.66337,447.442,080,243.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-24ORBIMED ADVISORS LLC10% Share HolderSell16,409.0024.45401,200.052,093,927.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-23ORBIMED ADVISORS LLC10% Share HolderSell3,541.0026.0592,243.052,110,336.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-02ORBIMED ADVISORS LLC10% Share HolderSell445,086.0026.0011,572,236.002,113,877.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000183/0000947871-20-000183-index.htm
2020-07-15Robert PaulChief Medical OfficerSell378.0023.588,913.24213,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120042869/0001209191-20-042869-index.htm
2020-07-15Robert PaulChief Medical OfficerSell9,622.0022.94220,728.68214,097.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120042869/0001209191-20-042869-index.htm
2020-06-15Robert PaulChief Medical OfficerSell3,909.0029.90116,879.10223,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120037254/0001209191-20-037254-index.htm
2020-06-15Robert PaulChief Medical OfficerSell6,091.0029.43179,258.13227,628.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120037254/0001209191-20-037254-index.htm
2020-05-15Robert PaulChief Medical OfficerSell2,104.0027.7858,449.12233,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120030604/0001209191-20-030604-index.htm
2020-05-15Robert PaulChief Medical OfficerSell5,996.0027.00161,892.00235,823.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120030604/0001209191-20-030604-index.htm
2020-05-15Robert PaulChief Medical OfficerSell1,900.0026.1549,685.00241,819.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120030604/0001209191-20-030604-index.htm
2020-04-15Robert PaulChief Medical OfficerSell10,000.0022.27222,700.00243,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120024871/0001209191-20-024871-index.htm
2019-02-11CARL L GORDONDirectorBuy50,561.0019.00960,659.002,455,853.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119009111/0001209191-19-009111-index.htm
2019-02-11ORBIMED ADVISORS LLCDirectorBuy50,561.0019.00960,659.002,455,853.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119009118/0001209191-19-009118-index.htm
2020-03-13Robert PaulChief Medical OfficerSell176.0024.464,304.96253,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm
2020-03-13Robert PaulChief Medical OfficerSell5,459.0023.49128,231.91253,895.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm
2020-01-09ORBIMED ADVISORS LLC10% Share HolderSell91,818.0019.501,790,451.002,558,963.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000023/0000947871-20-000023-index.htm
2020-03-13Robert PaulChief Medical OfficerSell2,884.0022.4764,803.48259,354.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm
2020-03-13Robert PaulChief Medical OfficerSell1,481.0021.5731,945.17262,238.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120019776/0001209191-20-019776-index.htm
2020-02-14Robert PaulChief Medical OfficerSell7,000.0029.74208,180.00263,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120010234/0001209191-20-010234-index.htm
2019-12-26ORBIMED ADVISORS LLC10% Share HolderSell2,325.0018.6043,245.002,650,781.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-24ORBIMED ADVISORS LLC10% Share HolderSell15,476.0019.59303,174.842,653,106.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-23ORBIMED ADVISORS LLC10% Share HolderSell20,350.0019.82403,337.002,668,582.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-20ORBIMED ADVISORS LLC10% Share HolderSell73,879.0019.661,452,461.142,688,932.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2020-02-14Robert PaulChief Medical OfficerSell3,000.0029.0787,210.00270,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120010234/0001209191-20-010234-index.htm
2020-01-15Robert PaulChief Medical OfficerSell10,000.0018.67186,700.00273,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120004048/0001209191-20-004048-index.htm
2020-01-23Robert PaulChief Medical OfficerSell599.0025.2215,106.78273,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005034/0001209191-20-005034-index.htm
2020-01-30Robert PaulChief Medical OfficerSell8,000.0028.00224,000.00273,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120006109/0001209191-20-006109-index.htm
2020-02-05Robert PaulChief Medical OfficerSell10,000.0032.10321,000.00273,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007732/0001209191-20-007732-index.htm
2020-01-23Robert PaulChief Medical OfficerSell5,401.0024.22130,812.22274,318.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005034/0001209191-20-005034-index.htm
2019-12-17ORBIMED ADVISORS LLC10% Share HolderSell205,793.0018.523,811,286.362,762,811.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000977/0000947871-19-000977-index.htm
2020-01-23Robert PaulChief Medical OfficerBuy6,000.008.1648,960.00279,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005034/0001209191-20-005034-index.htm
2020-01-30Robert PaulChief Medical OfficerBuy8,000.008.1665,280.00281,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120006109/0001209191-20-006109-index.htm
2020-02-05Robert PaulChief Medical OfficerBuy10,000.008.1681,600.00283,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007732/0001209191-20-007732-index.htm
2019-12-13Robert PaulChief Medical OfficerSell10,000.0020.03200,300.00283,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119060931/0001209191-19-060931-index.htm
2019-11-15Robert PaulChief Medical OfficerSell10,000.0015.93159,300.00293,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119057201/0001209191-19-057201-index.htm
2019-08-07ORBIMED ADVISORS LLC10% Share HolderSell157,636.0017.902,821,684.402,968,604.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000576/0000947871-19-000576-index.htm
2019-10-15Robert PaulChief Medical OfficerSell10,000.0014.68146,800.00301,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119053486/0001209191-19-053486-index.htm
2019-09-16Robert PaulChief Medical OfficerSell10,000.0019.08190,800.00311,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119050106/0001209191-19-050106-index.htm
2019-09-20Robert PaulChief Medical OfficerSell4,000.0020.0080,000.00311,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119050589/0001209191-19-050589-index.htm
2019-09-20Robert PaulChief Medical OfficerBuy4,000.008.1632,640.00315,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119050589/0001209191-19-050589-index.htm
2019-08-20Robert PaulChief Medical OfficerSell916.0016.0014,656.00321,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119046979/0001209191-19-046979-index.htm
2019-08-19Robert PaulChief Medical OfficerSell1,084.0016.0017,344.00322,635.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119046979/0001209191-19-046979-index.htm
2019-08-15Robert PaulChief Medical OfficerSell10,000.0014.19141,900.00323,719.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119046647/0001209191-19-046647-index.htm
2020-01-09ORBIMED ADVISORS LLC10% Share HolderSell1,392.0019.5027,144.0038,808.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000023/0000947871-20-000023-index.htm
2019-12-26ORBIMED ADVISORS LLC10% Share HolderSell1,200.0018.6022,320.0040,200.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-24ORBIMED ADVISORS LLC10% Share HolderSell8,000.0019.59156,720.0041,400.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2020-02-03David M. WehnerDirectorBuy20,000.0025.00500,000.0044,621.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120006112/0001209191-20-006112-index.htm
2020-05-15Robert KingChief Development OfficerSell3,003.0027.7883,423.34477,317.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120030601/0001209191-20-030601-index.htm
2020-05-15Robert KingChief Development OfficerSell8,632.0027.02233,236.64480,320.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120030601/0001209191-20-030601-index.htm
2020-05-15Robert KingChief Development OfficerSell3,365.0026.2488,297.60488,952.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120030601/0001209191-20-030601-index.htm
2020-02-14Robert KingChief Development OfficerSell10,332.0029.77307,583.64492,317.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120010241/0001209191-20-010241-index.htm
2019-12-23ORBIMED ADVISORS LLC10% Share HolderSell10,400.0019.82206,128.0049,400.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2020-02-14Robert KingChief Development OfficerSell4,668.0029.09135,792.12502,649.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120010241/0001209191-20-010241-index.htm
2020-01-22Robert KingChief Development OfficerSell3.0022.0166.03507,317.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120004706/0001209191-20-004706-index.htm
2020-01-21Robert KingChief Development OfficerSell14,997.0022.01330,083.97507,320.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120004706/0001209191-20-004706-index.htm
2019-11-15Robert KingChief Development OfficerSell7,500.0015.92119,400.00522,317.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119057203/0001209191-19-057203-index.htm
2019-08-19Robert KingChief Development OfficerSell7,500.0015.00112,500.00529,817.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119046985/0001209191-19-046985-index.htm
2020-02-07Sabah OneyChief Business OfficerSell19,900.0035.03697,097.00573,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120008414/0001209191-20-008414-index.htm
2020-02-06Sabah OneyChief Business OfficerSell100.0035.003,500.00593,818.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007250/0001209191-20-007250-index.htm
2019-09-20Sabah OneyChief Business OfficerSell400.0020.008,000.00593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119050590/0001209191-19-050590-index.htm
2019-12-05Sabah OneyChief Business OfficerSell1,500.0020.0030,000.00593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2019-12-06Sabah OneyChief Business OfficerSell5,156.0020.02103,223.12593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2019-12-09Sabah OneyChief Business OfficerSell2,300.0020.0746,161.00593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2019-12-10Sabah OneyChief Business OfficerSell500.0020.0110,005.00593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119060225/0001209191-19-060225-index.htm
2019-12-12Sabah OneyChief Business OfficerSell6,810.0020.13137,068.96593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119060784/0001209191-19-060784-index.htm
2020-01-23Sabah OneyChief Business OfficerSell2,200.0025.2155,462.00593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm
2020-01-27Sabah OneyChief Business OfficerSell14,467.0025.05362,398.35593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm
2020-02-04Sabah OneyChief Business OfficerSell16,667.0030.00500,010.00593,918.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007250/0001209191-20-007250-index.htm
2019-09-20Sabah OneyChief Business OfficerBuy400.008.163,264.00594,318.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119050590/0001209191-19-050590-index.htm
2019-12-10Sabah OneyChief Business OfficerBuy500.008.164,080.00594,418.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119060225/0001209191-19-060225-index.htm
2019-12-05Sabah OneyChief Business OfficerBuy1,500.008.1612,240.00595,418.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2020-04-16ORBIMED ADVISORS LLC10% Share HolderSell47,097.0023.531,108,192.415,955,674.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm
2020-01-23Sabah OneyChief Business OfficerBuy2,200.008.1617,952.00596,118.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm
2019-12-09Sabah OneyChief Business OfficerBuy2,300.008.1618,768.00596,218.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2019-12-20ORBIMED ADVISORS LLC10% Share HolderSell37,900.0019.66745,114.0059,800.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-06Sabah OneyChief Business OfficerBuy5,156.008.1642,072.96599,074.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119059767/0001209191-19-059767-index.htm
2020-04-14ORBIMED ADVISORS LLC10% Share HolderSell17,595.0023.52413,834.406,002,771.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000388/0000947871-20-000388-index.htm
2019-12-12Sabah OneyChief Business OfficerBuy6,810.008.1655,569.60600,728.00https://www.sec.gov/Archives/edgar/data/1653087/000120919119060784/0001209191-19-060784-index.htm
2020-04-09ORBIMED ADVISORS LLC10% Share HolderSell218,208.0023.795,191,168.326,020,366.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-01-27Sabah OneyChief Business OfficerBuy14,467.008.16118,050.72608,385.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120005043/0001209191-20-005043-index.htm
2020-02-04Sabah OneyChief Business OfficerBuy16,667.008.16136,002.72610,585.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007250/0001209191-20-007250-index.htm
2020-04-08ORBIMED ADVISORS LLC10% Share HolderSell62,573.0023.651,479,851.456,238,574.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-04-07ORBIMED ADVISORS LLC10% Share HolderSell6,946.0023.10160,452.606,301,147.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000371/0000947871-20-000371-index.htm
2020-03-31ORBIMED ADVISORS LLC10% Share HolderSell189,355.0024.504,639,197.506,308,093.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000317/0000947871-20-000317-index.htm
2020-03-25ORBIMED ADVISORS LLC10% Share HolderSell42,727.0024.661,053,647.826,497,448.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-24ORBIMED ADVISORS LLC10% Share HolderSell51,235.0024.451,252,695.756,540,175.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-23ORBIMED ADVISORS LLC10% Share HolderSell11,057.0026.05288,034.856,591,410.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000288/0000947871-20-000288-index.htm
2020-03-02ORBIMED ADVISORS LLC10% Share HolderSell1,390,309.0026.0036,148,034.006,602,467.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000183/0000947871-20-000183-index.htm
2020-01-09ORBIMED ADVISORS LLC10% Share HolderSell286,787.0019.505,592,346.507,992,776.00https://www.sec.gov/Archives/edgar/data/1653087/000094787120000023/0000947871-20-000023-index.htm
2019-12-26ORBIMED ADVISORS LLC10% Share HolderSell7,275.0018.60135,315.008,279,563.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-24ORBIMED ADVISORS LLC10% Share HolderSell48,324.0019.59946,667.168,286,838.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-23ORBIMED ADVISORS LLC10% Share HolderSell63,535.0019.821,259,263.708,335,162.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-20ORBIMED ADVISORS LLC10% Share HolderSell230,721.0019.664,535,974.868,398,697.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000992/0000947871-19-000992-index.htm
2019-12-17ORBIMED ADVISORS LLC10% Share HolderSell642,807.0018.5211,904,785.648,629,418.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000977/0000947871-19-000977-index.htm
2019-08-07ORBIMED ADVISORS LLC10% Share HolderSell492,364.0017.908,813,315.609,272,225.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000576/0000947871-19-000576-index.htm
2019-12-17ORBIMED ADVISORS LLC10% Share HolderSell105,500.0018.521,953,860.0097,700.00https://www.sec.gov/Archives/edgar/data/1653087/000094787119000977/0000947871-19-000977-index.htm
2020-02-04RICHARD H SCHELLERDirectorSell10,000.0029.67296,700.009,981.00https://www.sec.gov/Archives/edgar/data/1653087/000120919120007210/0001209191-20-007210-index.htm